Muscle & Nervous Tissue

Imagine touching a hot stove. Within a fraction of a second your hand has already jerked away. Your heart rate has ticked upward. The blood vessels in your skin have constricted. Three completely different tissues execute three different mechanical and electrical responses. All are triggered by the same alarming stimulus. This coordinated speed is only possible because animals evolved two specialized tissue types. They are built around a shared electrical trick: the excitable membrane. Muscle and nervous tissue are the "action" tissues of the body. Epithelium covers and secretes, connective tissue supports and connects. But muscle and nerve do things — they generate force, move fluids, and carry information. They do this across distances of a meter or more in milliseconds. What unites them mechanistically is excitability. Both cell types maintain a resting voltage across their plasma membrane. Both can rapidly and transiently reverse it. This produces an Action Potential that either triggers contraction (muscle) or propagates a signal to the next cell (nerve). The big picture is that physiology is fundamentally a problem of communication and force generation under homeostatic constraint. A muscle fiber is a tiny motor; a neuron is a tiny wire. Both convert chemical energy and ionic gradients into functional output. Both are built from cells so specialized that they have essentially given up dividing in the adult body. They trade this in exchange for extreme performance. Understanding how they work — and how physiologists proved it — explains a lot. It explains why your biceps fatigues but your heart never does. It explains why a nerve gas kills by paralyzing the diaphragm. This article builds the mechanism from the molecular level (ion channels, Sarcomere proteins, neurotransmitter vesicles) up to organ-level behavior (tetanus, cardiac refractory periods, peristalsis). It then walks through the classical experiments that turned inference into proof. These include Hodgkin and Huxley's voltage clamp, the sliding filament work of Huxley and Hanson, and the neuromuscular junction studies of Katz.

Key takeaways
  • Muscle (skeletal, cardiac, smooth) and neurons are both excitable tissues: they use voltage-gated ion channels to generate action potentials.
  • Skeletal muscle contracts by the sliding filament mechanism: myosin heads walk along actin, pulling Z-discs closer without the filaments themselves shortening.
  • Ca²⁺ is the universal contraction trigger, but the trigger protein differs: troponin in skeletal/cardiac muscle, calmodulin/MLCK in smooth muscle.
  • Cardiac muscle is electrically syncytial (gap junctions) and has a long refractory period, which prevents tetanus and protects the heartbeat rhythm.
  • Neurons transmit information as all-or-none action potentials along axons and convert it to graded chemical signals at synapses via vesicle release.
  • Hodgkin and Huxley's voltage-clamp experiments (1952) and Katz's quantal release studies proved the ionic and chemical mechanisms with quantitative precision, not just description.
The core insight

Excitable tissues convert transient, voltage-gated ion fluxes into either mechanical force (muscle) or propagated information (nerve), using shared electrochemical machinery for fundamentally different biological jobs.

The core idea

Muscle and nervous tissue are grouped together because both are excitable: their plasma membranes contain voltage-gated ion channels that allow a resting membrane potential to be rapidly and regeneratively reversed. This event, the Action Potential, is an all-or-none electrical signal that travels along the membrane without decrement. In neurons the action potential is the output — it carries information from dendrite to axon terminal, where it is converted into a chemical signal at a synapse. In muscle, the action potential is an intermediate step: it is coupled, through a process called excitation-contraction coupling, to the release of calcium ions that switch on the mechanical contractile apparatus. Three types of muscle exist, distinguished by structure, control, and location, but they share the same fundamental engine — the actin-myosin cross-bridge cycle, powered by ATP hydrolysis. Skeletal muscle is striated, multinucleated, and under voluntary (somatic motor neuron) control; it moves the skeleton. Cardiac muscle is striated, mononucleated (or binucleated), branched, and electrically connected by gap junctions; it is involuntary and intrinsically rhythmic. Smooth muscle is non-striated, spindle-shaped, and involuntary; it lines hollow organs and blood vessels, and is controlled by autonomic nerves, hormones, and local stretch. The presence or absence of visible striations reflects whether actin and myosin are arranged into a highly ordered repeating unit (the sarcomere) or a looser, more variable lattice. Nervous tissue, meanwhile, is built from two broad cell classes: neurons, which generate and conduct electrical signals, and glia (astrocytes, oligodendrocytes/Schwann cells, microglia, ependymal cells), which support, insulate, and metabolically sustain neurons but do not themselves fire action potentials in the classical sense. A neuron's functional geometry — dendrites collecting input, a cell body integrating it, an axon conducting a decision, and a terminal releasing neurotransmitter — is a direct anatomical expression of the physiological principle that information must be received, integrated, and transmitted in one direction (functionally, if not always strictly anatomically).

Mechanism

1. The resting membrane potential. Every excitable cell maintains a negative internal voltage — roughly −70 mV in neurons and skeletal muscle, −90 mV in ventricular myocytes — established mainly by a high resting permeability to K⁺ relative to Na⁺, and maintained energetically by the Na⁺/K⁺-ATPase, which pumps 3 Na⁺ out and 2 K⁺ in per ATP hydrolyzed. Because K⁺ channels leak more than Na⁺ channels at rest, the membrane potential sits close to (but not exactly at) the K⁺ equilibrium potential predicted by the Nernst equation.

2. Threshold and the action potential. A depolarizing stimulus (synaptic current in a neuron, end-plate potential in skeletal muscle, gap-junction current in cardiac muscle) that pushes the membrane past threshold (typically ~−55 mV) opens voltage-gated Na⁺ channels. This produces a positive-feedback loop: Na⁺ influx depolarizes the membrane, which opens more Na⁺ channels. The membrane potential overshoots toward +30 mV before Na⁺ channels inactivate and delayed-rectifier voltage-gated K⁺ channels open, repolarizing the cell. A brief afterhyperpolarization follows before Na⁺/K⁺-ATPase and leak channels restore rest.

3. Excitation-contraction coupling in skeletal muscle. The action potential, initiated at the neuromuscular junction, propagates along the sarcolemma and dives inward along T-tubules. Voltage sensors here (dihydropyridine receptors, DHPRs) are mechanically coupled to ryanodine receptors (RyR1) on the adjacent sarcoplasmic reticulum (SR). Depolarization causes a conformational change in the DHPR that directly forces RyR1 open — a direct mechanical link, not a chemical one, which is why skeletal muscle can contract even without extracellular Ca²⁺. Ca²⁺ floods from the SR into the cytosol (from ~10⁻⁷ M to ~10⁻⁵ M), binds troponin C, and shifts the troponin-tropomyosin complex off the myosin-binding sites on actin.

4. The cross-bridge cycle (sliding filament mechanism). With binding sites exposed, myosin heads (already charged with ADP + Pi from prior ATP hydrolysis) bind actin, release Pi, and undergo the power stroke — rotating and pulling the actin filament toward the sarcomere's center. ADP is then released, ATP binds the myosin head, causing detachment, and ATP hydrolysis re-cocks the head for another cycle. Filaments themselves do not shorten; the thin (actin) filaments slide past the thick (myosin) filaments, narrowing the I-band and H-zone while the A-band stays constant — the defining signature of the sliding filament theory.

5. Relaxation. Ca²⁺ is pumped back into the SR by SERCA (sarco/endoplasmic reticulum Ca²⁺-ATPase); as cytosolic Ca²⁺ falls, troponin releases Ca²⁺, tropomyosin re-blocks the binding sites, and cross-bridge cycling stops. Rigor mortis occurs postmortem precisely because ATP runs out and myosin heads cannot detach from actin.

6. Cardiac muscle — the same cycle, different triggers and wiring. Cardiac myocytes use calcium-induced calcium release: extracellular Ca²⁺ entering through L-type Ca²⁺ channels during the action potential's plateau phase triggers RyR2 to release a larger pulse of Ca²⁺ from the SR. Gap junctions at intercalated discs electrically couple myocytes into a functional syncytium, so an action potential starting in the sinoatrial node spreads cell-to-cell without needing individual synapses. Cardiac action potentials have a long plateau (Ca²⁺ channels staying open ~200–300 ms), which produces a correspondingly long absolute refractory period — this is a safety feature: it prevents the heart from being re-excited before it has mechanically relaxed, making tetanic contraction of the heart physiologically impossible.

7. Smooth muscle — no troponin, a different amplifier. Smooth muscle lacks troponin. Ca²⁺ instead binds calmodulin, and the Ca²⁺-calmodulin complex activates myosin light-chain kinase (MLCK), which phosphorylates the myosin regulatory light chain, permitting cross-bridge cycling. Relaxation requires myosin light-chain phosphatase to dephosphorylate myosin. Smooth muscle also lacks the fixed sarcomeric geometry of striated muscle, allowing it to contract effectively over a much wider range of lengths — essential for hollow organs like the bladder and stomach that must function whether empty or distended.

8. Synaptic transmission — the neuron's version of excitation-contraction coupling. When an action potential reaches an axon terminal, depolarization opens voltage-gated Ca²⁺ channels; Ca²⁺ influx triggers synaptic vesicles to fuse with the presynaptic membrane (via SNARE proteins) and release neurotransmitter into the synaptic cleft. At the neuromuscular junction specifically, acetylcholine binds nicotinic receptors on the muscle end plate, opening ligand-gated cation channels that depolarize the sarcolemma and initiate the whole excitation-contraction cascade described above. This is the literal handshake between nervous and muscular tissue.

Figure
Excitation-contraction coupling: from action potential to cross-bridge cycling
Skeletal Muscle Excitation–Contraction Coupling Sarcolemma (action potential) T-tubule DHPR (voltage sensor) Sarcoplasmic Reticulum RyR1 channel Ca²⁺ released into cytosol Actin (thin filament) Myosin (thick filament) with heads Troponin (binds Ca²⁺) shifts tropomyosin off binding sites Ca²⁺ diffuses to thin filament Power stroke pulls actin →
Figure
Comparing the three muscle types: structure and control
Skeletal vs Cardiac vs Smooth Muscle Skeletal Striated, multinucleate, unbranched, voluntary Trigger: nerve (ACh) → troponin No tetanus limit at physiological rates Cardiac Striated, 1–2 nuclei, branched, gap junctions Trigger: pacemaker + Ca²⁺-induced Long refractory period → no tetanus Smooth Non-striated, spindle-shaped, single nucleus, involuntary Trigger: Ca²⁺-calmodulin-MLCK Wide length range; tonic contraction

The evidence

Hodgkin and Huxley — the voltage clamp and the ionic basis of the action potential (1952). Working on the giant axon of the squid Loligo — chosen because its diameter (up to ~1 mm) was large enough to thread with wire electrodes — Alan Hodgkin and Andrew Huxley used the voltage clamp technique (with Kenneth Cole) to hold the membrane at a fixed voltage and measure the resulting ionic currents directly, eliminating the confound of the membrane potential changing during measurement. By substituting choline for Na⁺ in the seawater bathing the axon, they could isolate the Na⁺ and K⁺ components of the current. They found an early transient inward current (Na⁺) followed by a delayed, sustained outward current (K⁺), and they quantitatively modeled the voltage- and time-dependence of the underlying conductances. Their equations correctly predicted the action potential's shape, threshold, refractory period, and conduction velocity — a triumph confirmed when they reconstructed the action potential numerically and it matched the recorded waveform almost exactly. This work won the 1963 Nobel Prize in Physiology or Medicine and remains the quantitative foundation for all modern excitable-membrane physiology.

Huxley, Hanson, and Huxley — the sliding filament theory (1954). Two independent teams — Andrew Huxley with Rolf Niedergerke, and Hugh Huxley with Jean Hanson — published back-to-back papers in Nature in 1954 using light and electron microscopy (interference microscopy for the former, EM for the latter) on isolated muscle fibers. They observed that as a sarcomere shortens during contraction, the A-band length stays constant while the I-band and H-zone shrink. This was the critical, falsifiable prediction: if filaments themselves shortened, the A-band (defined by myosin thick filament length) should also shrink. Instead, only the regions where thin filaments were absent from overlap shrank, proving that filaments slide past one another rather than contracting individually. This directly established the sliding filament model that underlies all of muscle mechanics.

Bernard Katz — quantal transmitter release at the neuromuscular junction (1950s). Recording intracellularly from frog neuromuscular junctions, Katz and colleagues (Paul Fatt, Jose del Castillo) noticed small, spontaneous depolarizations at the motor end plate even without nerve stimulation — miniature end-plate potentials (MEPPs), each roughly 0.4–1.0 mV. Crucially, the evoked end-plate potential, when transmitter release was weakened (low Ca²⁺, high Mg²⁺), varied in discrete steps that were always integer multiples of the MEPP size. This statistical, quantal pattern demonstrated that acetylcholine is released not continuously but in fixed packets ("quanta"), each corresponding to the contents of one synaptic vesicle. Katz shared the 1970 Nobel Prize for this work, and it established the vesicular, quantal model of chemical synaptic transmission that underlies modern neuroscience and pharmacology (and explains why toxins like botulinum, which block vesicle fusion, are so devastating).

Otto Loewi's "Vagusstoff" experiment (1921). Loewi electrically stimulated the vagus nerve of an isolated frog heart, slowing its rate, then transferred the perfusate bathing that heart to a second isolated heart — which also slowed, even though its own vagus had not been stimulated. This proved that nerves communicate with target organs via a diffusible chemical substance (later identified as acetylcholine), not purely by direct electrical contact, founding the field of chemical neurotransmission. Loewi reportedly conceived the experiment in a dream and performed it the next morning — a story he himself recounted in his Nobel lecture.

Worked examples

Example 1 — Predicting refractory behavior from a stimulation frequency. A skeletal muscle motor unit has an absolute refractory period of about 1–2 ms and a twitch duration of roughly 100 ms. A cardiac ventricular myocyte has an absolute refractory period of about 250 ms, comparable to its own twitch (systole) duration. Suppose a physiologist stimulates each tissue at 50 Hz (one stimulus every 20 ms).

  • Skeletal muscle: 20 ms between stimuli is far longer than the ~1–2 ms refractory period, so each stimulus can trigger a new action potential and add more Ca²⁺ release before the previous twitch relaxes. Because twitch duration (100 ms) vastly exceeds the interstimulus interval (20 ms), successive twitches summate, and at 50 Hz the muscle reaches fused (complete) tetanus — smooth, sustained maximal tension.
  • Cardiac muscle: 20 ms between stimuli is much shorter than the ~250 ms refractory period. The second stimulus arrives while the cell is still absolutely refractory, so it produces no additional action potential at all — the stimulus is simply ignored. The heart cannot be tetanized at any physiologically survivable frequency.

This single comparison explains, mechanistically, why skeletal muscle can sustain smooth, forceful contraction (useful for holding posture or lifting a weight) while cardiac muscle is protected from ever locking into sustained contraction, which would be fatal (the heart must relax completely between beats to refill).

Example 2 — A clinical reasoning case: myasthenia gravis. A 34-year-old woman presents with drooping eyelids (ptosis) and muscle weakness that worsens through the day and improves with rest. Repetitive nerve stimulation testing shows a decrementing compound muscle action potential (each successive stimulus produces a smaller muscle response than the last). Reasoning through the mechanism: in myasthenia gravis, autoantibodies target nicotinic acetylcholine receptors on the postsynaptic muscle end plate, reducing their number. Presynaptically, ACh release and quantal content (as Katz described) remain normal — the neuron still fires and releases its normal quota of vesicles. But with fewer receptors available, each end-plate potential (EPP) is smaller than normal. Normally an EPP is several-fold larger than needed to reach the threshold for a muscle action potential — a large safety factor. With receptor loss, this safety factor shrinks; repetitive stimulation causes normal, mild rundown of ACh release (which happens even in healthy synapses) to push some EPPs below threshold, so a smaller and smaller fraction of muscle fibers fire with each successive stimulus, producing the decrementing electrical response and clinically manifesting as fatigable weakness. Treatments (acetylcholinesterase inhibitors like pyridostigmine) work by prolonging ACh's presence in the synaptic cleft, letting it act on the remaining receptors longer and effectively restoring some of the lost safety factor — a direct clinical application of Katz's quantal transmission mechanism.

Common misconceptions & traps

MisconceptionWhy it's wrong
"Muscles shorten because the filaments themselves contract."Actin and myosin filaments keep a constant length; only the overlap changes as they slide past each other (the sliding filament theory, not "shortening filament" theory).
"Action potentials get smaller as they travel down a long axon."Action potentials are all-or-none and regenerated at each point along the membrane by fresh voltage-gated channel opening — they do not decay in amplitude, unlike passive graded potentials.
"Calcium causes contraction the same way in all muscle types."Only skeletal/cardiac muscle uses troponin; smooth muscle uses calmodulin and MLCK — a distinct biochemical trigger, not a universal one.
"Cardiac muscle can be tetanized with strong enough or fast enough stimulation."Its long absolute refractory period (~250 ms) makes a second action potential physically impossible before repolarization is well underway, regardless of stimulus strength.
"Neurons and glia both fire action potentials."Glia (astrocytes, oligodendrocytes, microglia) support and insulate neurons but generally lack the dense voltage-gated Na⁺ channel arrays needed for classical action potentials.
"More ATP means a stronger, faster contraction."ATP is required for cross-bridge cycling and for detachment/relaxation (its absence causes rigor); contraction strength is set primarily by Ca²⁺ availability and fiber recruitment, not ATP surplus.

The scientist behind it

Alan Lloyd Hodgkin trained as a zoologist at Cambridge before the outbreak of the Second World War interrupted his research; he spent the war years working on radar for the Air Ministry, which sharpened his skill with electronic circuits — a skill that proved essential when he returned to build the voltage-clamp apparatus. After the war, he partnered with a younger colleague, Andrew Huxley, at the Plymouth Marine Laboratory, where the local abundance of squid provided the giant axon preparation their work depended on. Their 1952 series of five papers in the Journal of Physiology is often cited as one of the most complete and quantitatively rigorous physiological investigations ever published — not just a description of a phenomenon but a predictive mathematical model derived directly from controlled experimental measurement.

Origins · 1 minAlan Lloyd Hodgkin and how this was discovered
AL
Alan Lloyd Hodgkin
1914–1998 · Cambridge/Plymouth, mid-20th-century electrophysiology

Hodgkin combined wartime radar-electronics expertise with squid giant axon preparations to build the voltage clamp, turning the action potential from a described phenomenon into a quantitatively predicted one.

History
- 1921 — Otto Loewi demonstrates chemical (vagal) neurotransmission using two perfused frog hearts.
- 1939 — Hodgkin and Huxley first record an action potential directly from inside a squid giant axon.
- 1952 — Hodgkin and Huxley publish the voltage-clamp series, quantitatively explaining the ionic basis of the action potential.
- 1954 — A. F. Huxley/Niedergerke and H. E. Huxley/Hanson independently establish the sliding filament theory of muscle contraction.
- 1950s–1970s — Bernard Katz establishes quantal neurotransmitter release at the neuromuscular junction.

Where this matters today

Medicine. Local anesthetics (lidocaine) block voltage-gated Na⁺ channels, directly exploiting the Hodgkin-Huxley mechanism to prevent action potential propagation in pain fibers. Antiarrhythmic drugs are classified (the Vaughan Williams classification) by exactly which ion channel or receptor they target — Na⁺ channel blockers, K⁺ channel blockers, Ca²⁺ channel blockers, beta-blockers — a direct clinical translation of cardiac electrophysiology. Understanding troponin's role in cardiac excitation-contraction coupling underlies the troponin blood test, the primary diagnostic marker for myocardial infarction, because damaged heart muscle releases cardiac-specific troponin isoforms into the bloodstream.

Neuromuscular pharmacology and toxicology. Botulinum toxin blocks SNARE-mediated vesicle fusion at the neuromuscular junction (exploited clinically in Botox for focal dystonia and cosmetically for wrinkles); organophosphate nerve agents and pesticides inhibit acetylcholinesterase, flooding the synapse with ACh and causing sustained depolarization block — paralysis by the opposite mechanism to myasthenia gravis. Curare-like neuromuscular blockers (used in surgical anesthesia) competitively block nicotinic ACh receptors to induce controlled, reversible paralysis.

Biotechnology and physiology research. Patch-clamp electrophysiology, a direct descendant of Hodgkin and Huxley's voltage clamp (refined by Neher and Sakmann to resolve single-channel currents), remains the gold-standard technique for studying ion channels and is central to drug screening for cardiac safety (the hERG channel assay, checking that new drugs don't cause fatal arrhythmias).

Sports physiology and rehabilitation. Muscle fiber typing (slow oxidative vs. fast glycolytic) built on this same contractile machinery informs training regimens, while understanding motor unit recruitment and tetanic fusion frequency underlies functional electrical stimulation therapies for spinal cord injury and stroke rehabilitation.

Agriculture and conservation. Anesthetic and tranquilizer protocols for livestock and wildlife immobilization (e.g., etorphine, succinylcholine-based darting) rely on precisely the neuromuscular blockade mechanisms described here, and understanding cardiac refractory periods informs defibrillation protocols used in both veterinary and human emergency medicine.

Ask the tutor: How does the length-tension relationship in sarcomeres explain why overstretched or overcompressed muscle generates less force?

Why don't skeletal muscle and neurons keep contracting/firing forever once activated?

Both tissues have built-in shut-off mechanisms. In neurons, voltage-gated Na⁺ channels inactivate within about a millisecond, and K⁺ channels repolarize the membrane, ending the action potential; a refractory period then prevents immediate re-firing. In skeletal muscle, after the action potential passes, SERCA pumps actively resequester Ca²⁺ back into the sarcoplasmic reticulum, cytosolic Ca²⁺ falls, troponin releases it, and tropomyosin re-blocks the actin binding sites, halting cross-bridge cycling. Both processes require ongoing ATP consumption to actively reset the resting state, which is why extreme ATP depletion (as after death) leaves muscle unable to relax, producing rigor mortis.

Is smooth muscle really "involuntary," and does it use action potentials the same way skeletal muscle does?

Smooth muscle is autonomically controlled and not subject to conscious voluntary control, but its electrical behavior is more varied than skeletal muscle's. Some smooth muscle (single-unit, e.g., in the gut) is electrically coupled by gap junctions and generates spontaneous, rhythmic slow waves and action potentials that spread across whole sheets of cells, similar in principle to cardiac tissue. Other smooth muscle (multi-unit, e.g., in the iris or vas deferens) behaves more like independent units activated individually by autonomic nerve input, sometimes without full action potentials at all, relying instead on graded depolarizations that still raise Ca²⁺ enough to trigger the calmodulin-MLCK pathway.

Why does the heart's long refractory period matter physiologically, beyond just preventing tetanus?

The extended refractory period, driven by prolonged Ca²⁺ channel opening during the action potential plateau, ensures that the ventricles cannot be re-excited until they have substantially completed their mechanical contraction and begun relaxing. This protects the heart from lethal arrhythmias that could arise if an ectopic electrical wave re-entered contracting tissue too early (a mechanism underlying dangerous re-entrant arrhythmias when refractory periods are pathologically shortened or tissue is damaged, as after a myocardial infarction). It effectively guarantees a mandatory relaxation and filling phase between every beat.

How exactly does one action potential in a neuron become a chemical signal at a synapse?

When the action potential depolarizes the axon terminal, voltage-gated Ca²⁺ channels open, and the resulting local Ca²⁺ influx triggers synaptic vesicles — pre-docked at the presynaptic membrane via SNARE protein complexes — to fuse with the membrane and release their neurotransmitter contents into the synaptic cleft by exocytosis. The neurotransmitter diffuses across the roughly 20-nanometer cleft and binds specific receptors on the postsynaptic cell, which may be ligand-gated ion channels (fast, direct, ionotropic) or G-protein-coupled receptors (slower, indirect, metabotropic). This conversion from electrical to chemical and back to electrical signal is what allows information to cross the physical gap between cells, and it is the step Katz's quantal-release experiments dissected in molecular detail.

Why is skeletal muscle striated but smooth muscle is not, if both use actin and myosin?

Striation comes from the highly regular, repeating arrangement of thick and thin filaments into sarcomeres bounded by Z-discs, precisely aligned across the width of the fiber — this alignment is what produces the alternating light and dark bands visible microscopically. Smooth muscle contains the same actin and myosin proteins but arranges them in irregular, obliquely oriented bundles anchored to dense bodies scattered throughout the cytoplasm rather than to aligned Z-discs. This looser architecture sacrifices the fast, powerful, precisely graded contraction of striated muscle for the ability to contract over a much broader range of cell lengths, which is essential for organs like the bladder or uterus that must generate force whether nearly empty or greatly distended.

Do all muscle fibers within a motor unit contract with the same strength, and what determines overall force?

Individual muscle fibers obey the all-or-none principle at the level of a single action potential producing a single twitch, but whole-muscle force is graded by two independent mechanisms: recruitment (how many motor units, each controlling a bundle of fibers, are activated) and rate coding (how fast each active motor unit's neuron fires, since summation and tetanic fusion increase force per unit up to a maximum). Smaller, more excitable motor units (slow oxidative fibers) are recruited first for fine or sustained tasks, with larger, more powerful motor units (fast glycolytic fibers) recruited progressively for greater force needs — the size principle of motor unit recruitment.

Why can't neurons and cardiac/skeletal muscle just "regenerate" after major damage the way skin does?

Mature neurons and (to a large extent) cardiac myocytes exit the cell cycle permanently, trading proliferative capacity for the extreme structural and metabolic specialization needed for rapid, reliable excitability and, in muscle, force generation. Skeletal muscle retains a partial regenerative reserve through satellite cells, quiescent muscle stem cells that can be activated to fuse and repair damaged fibers, which is why skeletal muscle recovers from many injuries far better than cardiac muscle, where myocyte loss after a heart attack is largely replaced by non-contractile scar tissue rather than new muscle. This differential regenerative capacity is a major target of current regenerative-medicine and stem-cell research.

Before this